|Opportunity Name||2023 Research Grant Program|
|Agency||Brain Tumour Foundation of Canada|
|Value||Up to $25,000|
|Duration||Up to 2 years|
|Application due to FSc RO at email@example.com for full review||08-03-2023|
|Application and fully signed ORS checklist due to FSc RO at firstname.lastname@example.org for mandatory review||08-11-2023|
|Final application and fully signed ORS checklist due at ORS for mandatory review||08-16-2023, by 9:00AM|
|Application due at agency||08-18-2023|
The Foundation is seeking outstanding researchers conducting quality brain tumour research.
All proposal will be given consideration. Additionally, the Foundation is interested in receiving innovative research proposals which incorporate novel or original concepts that have the potential to make a difference and projects that involve collaboration.
Applications will be considered for Basic, Clinical, Translational Research and Populations Studies.
Basic Research: the development of new concepts (e.g., signaling pathways using an in vitro model). Basic science research is meant to increase our scientific knowledge base, with the intent of bettering our understanding of the cause and progression of brain tumours.
Clinical Research: Research in which people, or data or samples of tissue from people, are studied to understand health and disease. Clinical research helps find new and better ways to detect, diagnose, treat, and prevent disease. Types of clinical research include clinical trials, which test new treatments for a disease, and natural history studies, which collect health information to understand how a disease develops and progresses over time.
Translational Research: pre-clinical research evaluating the therapeutic potential of recent discoveries in the basic mechanisms of either brain tumour pathogenesis or experimental therapeutics. Human studies are excluded.
Population Studies: A study of a group of individuals taken from the general population who share a common characteristic, such as age, sex, or health condition. This group may be studied for different reasons, such as their response to a drug or risk of getting a disease.
- The principal applicant must have an appointment at a university, research institute, hospital or like organization.
- The principal applicant must be the lead researcher on the project.
- Researchers who have received a grant from Brain Tumour Foundation of Canada the previous year are not eligible to apply.
- Grant recipients who have already submitted project report(s) may apply again two (2) years after their initial award.
How to Apply
York University researchers are reminded that all applications for external research funding, including Letters of Intent, must be reviewed and approved by the Office of Research Services before they are submitted to the granting agency. For internal approval, the application must be accompanied by a completed ORS Checklist, which requires the Dean’s signature. Please send the complete application, with the finalized budget and a completed ORS checklist to email@example.com, five days prior to agency deadline.
ORS is accepting electronic applications – the process is outlined here.